The UK NHS Bowel Cancer Screening Programme (http:// www.cancerscreening.nhs.uk/bowel) was introduced this year. In order to evaluate its impact on incidence and mortality for colorectal cancer, reliable data will be needed on trends in registrations for cancers of the colon and rectum, and in particular on tumour stage distribution, before and after the introduction of screening. Tumour stage is the main determinant of survival from colorectal cancer, and is expected to change substantially with screening. Data on stage and grade have formed part of the National Minimum Dataset for colorectal cancer collected by UK Cancer Registries since 1995, but are not included in published national statistics (Hayne et al, 2001; Quinn et al, 2001) . We describe data on colorectal cancer held by the Oxford Cancer Intelligence Unit for the years 1995 -2003.
MATERIALS AND METHODS
The Oxford Cancer Registry collects data on B1400 incident cases of colorectal cancer each year in Berkshire, Buckinghamshire, Northamptonshire and Oxfordshire (a population of B2.8 million). Since the early 1990s data have been obtained electronically directly from hospital pathology, oncology and patient administration records and from supplementary sources such as private hospitals and the Office for National Statistics. For invasive cancers of the colon (ICD10 C18) and of the rectum and related sites (ICD10 C19 -21) registered in 1995 -2003, the following variables were examined: year of diagnosis, age at diagnosis (in years), sex, Dukes stage (A, B, C, D or not staged/not stageable), grade (well, moderately, poorly or un-differentiated or not known) and morphology (using a histological classification based on that of WHO for tumours of the colon and rectum; Hamilton and Aaltonen, 2000) . Age-standardised registration rates were calculated by direct standardisation using the population of the catchment area in 2000 as reference.
RESULTS
Between 1995 and 2003, a total of 12 761 incident invasive colorectal cancers, 7865 of the colon and 4896 of the rectum and related sites (including 836 cancers of the rectosigmoid junction or of colon with rectum, C19; 3778 of rectum, C20, and 282 of anus and anal canal, C21), were registered. Characteristics of these cancers are shown in Table 1 . Classification by Dukes stage A -D was available for 81% of C18 cancers and for 69% of C19 -21 cancers; by grade for 76% of C18 and 81% of C19 -21 tumours; and by specified morphology for 86% of C18 and 92% of C19 -C21. Tumours classed by the registry as 'unknown' for any of these variables include those recorded as 'unstageable' and those with data missing. Data completeness did not show material variation between men and women (Table 1) or by year of diagnosis; the proportion of tumours of both colon and rectum classed as stage unknown was higher in those over 75 years at diagnosis than in younger patients (B25 vs B15%, respectively, for colon and B40 vs B25% for rectum). Age-standardised rates of registration of colorectal cancer were higher in men than in women and higher for colon than for rectal cancer throughout the period studied 
DISCUSSION
Detailed population-based evaluation of routine registry data will be important for the accurate interpretation of changes in cancer trends following the introduction of screening for colorectal cancer. This study of data from one of the nine cancer registries in England found that information on stage, grade and morphology of tumours has been collected consistently for colorectal cancers registered in the past 10 years. Registration rates and distribution of cancers by stage, grade and morphology remained relatively stable for the period 1995 -2003. Data on morphology were virtually complete for all cancers, but those on grade and stage were not. In particular, information on stage was not available for one-fifth of colon cancers and one-third of rectal cancers; and it 
